# INLYTA

NDC: 63539-044
Generic name: axitinib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20120127

FDA application: NDA202324

## Active ingredients

- AXITINIB: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-044
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a903e31-936e-4ed7-8a59-59f32374f338